| For: | Moal F, Veal N, Vuillemin E, Barrière E, Wang J, Fizanne L, Oberti F, Douay O, Gallois Y, Bonnefont-Rousselot D, Rousselet MC, Calès P. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats. World J Gastroenterol 2006; 12(41): 6639-6645 [PMID: 17075977 DOI: 10.3748/wjg.v12.i41.6639] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6639.htm |
| Number | Citing Articles |
| 1 |
Roger Flores‐Costa, José Alcaraz‐Quiles, Esther Titos, Cristina López‐Vicario, Mireia Casulleras, Marta Duran‐Güell, Bibiana Rius, Alba Diaz, Katherine Hall, Courtney Shea, Renee Sarno, Mark Currie, Jaime L Masferrer, Joan Clària. The soluble guanylate cyclase stimulator IW‐1973 prevents inflammation and fibrosis in experimental non‐alcoholic steatohepatitis. British Journal of Pharmacology 2018; 175(6) doi: 10.1111/bph.14137
|
| 2 |
Marko Sever, Anita Zenko Sever, Robert Klicek, Lucija Kralj, Marta Popovic Dolic, Kresimir Luetic, Dinko Bekic, Zeljka Belosic Halle, Mario Sucic, Suncana Sikiric, Lidija Beketic Oreskovic, Antun Bacic, Sanja Strbe, Eva Staresinic, Sven Seiwerth, Predrag Sikiric, Alenka Boban Blagaic, Ivan Dobric, Mario Staresinic, Anita Skrtic. Possibilities for Cytoprotective Liver Therapy, Stable Gastric Pentadecapeptide BPC 157, and Standard Agents—A Narrative Review. Pharmaceuticals 2026; 19(10) doi: 10.3390/ph19101559
|
| 3 |
Ya Zhang, Hang Zhao, Hua Li, Wei Cao, Fang Wang, Tian Zhang, Si-Wang Wang. Protective Effects of Amarogentin against Carbon Tetrachloride-Induced Liver Fibrosis in Mice. Molecules 2017; 22(5) doi: 10.3390/molecules22050754
|
| 4 |
Ebtehal El-Demerdash, Somaia A. Abdel-Sattar, Wesam M. El-Bakly, Eman A. Mohamed. Antifibrotic Effects of Carvedilol and Impact of Liver Fibrosis on Carvedilol Pharmacokinetics in a Rat model. European Journal of Drug Metabolism and Pharmacokinetics 2017; 42(5) doi: 10.1007/s13318-016-0391-9
|
| 5 |
Istvan Kovanecz, Amarnath Rambhatla, Monica G. Ferrini, Dolores Vernet, Sandra Sanchez, Jacob Rajfer, Nestor Gonzalez‐Cadavid. Chronic daily tadalafil prevents the corporal fibrosis and veno‐occlusive dysfunction that occurs after cavernosal nerve resection. BJU International 2008; 101(2) doi: 10.1111/j.1464-410X.2007.07223.x
|
| 6 |
Yusuf Ergün, Ergül Belge Kurutaş, Burhan Özdil, Ramazan Güneşaçar, Yılmaz Ergün. Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2011; 35(4) doi: 10.1016/j.clinre.2010.12.009
|
| 7 |
Edyta Maslak, Aleksandra Gregorius, Stefan Chlopicki. Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver. Pharmacological Reports 2015; 67(4) doi: 10.1016/j.pharep.2015.04.010
|
| 8 |
Shinichiro Fukuhara, Akira Tsujimura, Hidenobu Okuda, Keisuke Yamamoto, Tetsuya Takao, Yasushi Miyagawa, Norio Nonomura, Akihiko Okuyama. Vardenafil and Resveratrol Synergistically Enhance the Nitric Oxide/Cyclic Guanosine Monophosphate Pathway in Corpus Cavernosal Smooth Muscle Cells and its Therapeutic Potential for Erectile Dysfunction in the Streptozotocin-Induced Diabetic Rat: Preliminary Findings. The Journal of Sexual Medicine 2011; 8(4) doi: 10.1111/j.1743-6109.2010.02193.x
|
| 9 |
Rory P. Cunningham, Ryan D. Sheldon, R. Scott Rector. The Emerging Role of Hepatocellular eNOS in Non-alcoholic Fatty Liver Disease Development. Frontiers in Physiology 2020; 11 doi: 10.3389/fphys.2020.00767
|
| 10 |
Rafael Vercelino, Irene Crespo, Gabriela F. P. de Souza, Maria Jose Cuevas, Marcelo G. de Oliveira, Norma Possa Marroni, Javier González-Gallego, María Jesús Tuñón. S-nitroso-N-acetylcysteine attenuates liver fibrosis in cirrhotic rats. Journal of Molecular Medicine 2010; 88(4) doi: 10.1007/s00109-009-0577-6
|
| 11 |
Hala Salah Abdel-Kawy. Effect of carvedilol versus propranolol on acute and chronic liver toxicity in rats. Drug and Chemical Toxicology 2021; 44(1) doi: 10.1080/01480545.2019.1576718
|
| 12 |
Claire Edwards, Hong-Qiang Feng, Christopher Reynolds, Lan Mao, Don C. Rockey. Effect of the nitric oxide donor V-PYRRO/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice. American Journal of Physiology-Gastrointestinal and Liver Physiology 2008; 294(6) doi: 10.1152/ajpgi.00368.2007
|
| 13 |
|
| 14 |
Sureeporn Lomakool, Khomsan Ruangrit, Itthipon Jeerapan, Yingmanee Tragoolpua, Chayakorn Pumas, Sirasit Srinuanpan, Jeeraporn Pekkoh, Kritsana Duangjan. Biological activities and phytochemicals profiling of different cyanobacterial and microalgal biomass. Biomass Conversion and Biorefinery 2023; 13(5) doi: 10.1007/s13399-021-01974-0
|
| 15 |
Meritxell Perramón, María Navalón-López, Guillermo Fernández-Varo, Alazne Moreno-Lanceta, Rocío García-Pérez, Joana Faneca, Mario López-Moya, Cristina Fornaguera, Judith García-Villoria, Manuel Morales-Ruiz, Pedro Melgar-Lesmes, Salvador Borrós, Wladimiro Jiménez. Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats. Biomedicine & Pharmacotherapy 2024; 171 doi: 10.1016/j.biopha.2024.116143
|
| 16 |
Edyta Kus, Krzysztof Jasiński, Tomasz Skórka, Izabela Czyzynska-Cichon, Stefan Chlopicki. Short-term treatment with hepatoselective NO donor V-PYRRO/NO improves blood flow in hepatic microcirculation in liver steatosis in mice. Pharmacological Reports 2018; 70(3) doi: 10.1016/j.pharep.2017.11.019
|
| 17 |
Sarit Anavi, Michal Eisenberg-Bord, Michal Hahn-Obercyger, Olga Genin, Mark Pines, Oren Tirosh. The role of iNOS in cholesterol-induced liver fibrosis. Laboratory Investigation 2015; 95(8) doi: 10.1038/labinvest.2015.67
|
| 18 |
Daniel A. Langer, Amitava Das, David Semela, Ningling Kang-Decker, Helen Hendrickson, Steven F. Bronk, Zvonimir S. Katusic, Gregory J. Gores, Vijay H. Shah. Nitric oxide promotes caspase-independent hepatic stellate cell apoptosis through the generation of reactive oxygen species. Hepatology 2008; 47(6) doi: 10.1002/hep.22285
|
| 19 |
Edyta Maslak, Piotr Zabielski, Kamila Kochan, Kamil Kus, Agnieszka Jasztal, Barbara Sitek, Bartosz Proniewski, Tomasz Wojcik, Katarzyna Gula, Agnieszka Kij, Maria Walczak, Małgorzata Baranska, Adrian Chabowski, Ryan J. Holland, Joseph E. Saavedra, Larry K. Keefer, Stefan Chlopicki. The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. Biochemical Pharmacology 2015; 93(3) doi: 10.1016/j.bcp.2014.12.004
|